Additional Information on Patient Assistance Programs for Advanced Prostate Cancer

It has been brought to my attention that when I wrote the August 8, 2013 post on Pharma Sponsored Assistance Programs, I neglected to mention another excellent assistance program for men with advanced prostate cancer. The Chronic Disease Fund (CDF) has two funds that might be of specific interest to men with castrate resistant prostate [...]

An Email & A Response About Prostate Cancer & Family History

I received an email from a lady from Australia that I though would be informative to share. It discusses genetic links and risk factors for hormonally related (including prostate) cancers: HER EMAIL TO ME Hi there :) I hope you don't mind me emailing you? I'm a lady from Australia and have 3 uncles with [...]

Pharma Sponsored Patient Assistance Programs from PAN for Men with Prostate Cancer

There are a number of funds available to assist men with their treatment co-pays and to help cover travel for treatments. These funds receive their financial support from the drug companies (pharama) which make voluntary contributions. Within the overarching fund there are many disease specific funds that supply co-pay and or travel support for individuals. [...]

Side Effects of Xofigo – Are They Significant?

The following post is actually a response to a listserve issue over the side effects of Xofigo. I decided to post my response here to avoid the limit of lines allowed on the listserve and because I feel that it is also of interest to my regular readers of this blog. My response is using [...]

Testosterone Therapy for Prostate Cancer: Feeling Better while Defeating Cancer

Although there are now many new treatments for advanced prostate cancer, hormone therapy (ADT) has remained the standard of care for the last 70 years. While hormone therapy can provide pain relief, it is never curative. Long-term hormone therapy produces decreased quality of life. Men treated with hormone therapy have weight gain, experience impotence, decreased [...]

Go to Top